Patients in tissue kallikrein treatment group will be prescribed with intravenous infusion of tissue kallikrein ( @ PNAU/d , dissolved in @ ml saline ) for @ days after stenting and then oral administration of pancreatic kallikrein enteric-coated tablet ( @ U , @/d ) to the end of study .